0001564590-19-005808 Sample Contracts

EXECUTIVE EMPLOYMENT AGREEMENT
Executive Employment Agreement • March 1st, 2019 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances) • California

Employment Agreement (“Agreement”) made as of the 17th day of January, 2018 by and between Sangamo Therapeutics, Inc., a Delaware corporation (the “Company”), and Heather Turner (“Executive”) (2collectively, the “Parties”).

AutoNDA by SimpleDocs
FIRST AMENDMENT TO LEASE AGREEMENT BETWEEN MARINA BOULEVARD PROPERTY, LLC AND
Lease Agreement • March 1st, 2019 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances)
FIFTH AMENDMENT TO LEASE
Lease • March 1st, 2019 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances)

THIS FIFTH AMENDMENT TO LEASE (this ''Fifth Amendment") is entered into as of July 10, 2017 (the "Effective Date"), by and between POINT RICHMOND R&D ASSOCIATES II, LLC, a California limited liability company ("Landlord"), and SANGAMO THERAPEUTICS, INC., a Delaware corporation (formerly known as Sangamo Biosciences, Inc., a Delaware corporation) ("Tenant"), with reference to the following facts:

FOURTH AMENDMENT TO LEASE
Lease ( • March 1st, 2019 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances)
EXECUTIVE EMPLOYMENT AGREEMENT
Executive Employment Agreement • March 1st, 2019 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances) • California

Employment Agreement (“Agreement”) made as of the 18th day of November, 2018 by and between Sangamo Therapeutics, Inc., a Delaware corporation (the “Company”), and Adrian Woolfson (“Executive”) (collectively, the “Parties”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!